3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration.
about
MDMA for the treatment of mood disorder: all talk no substance?Improving the quality of biomarker candidates in untargeted metabolomics via peak table-based alignment of comprehensive two-dimensional gas chromatography-mass spectrometry data.Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniques.Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects.Key interindividual determinants in MDMA pharmacodynamics.Study on the metabolism of 5,6-methylenedioxy-2-aminoindane (MDAI) in rats: identification of urinary metabolites.
P2860
3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
3,4-Methylenedioxymethamphetam ...... ontrolled oral administration.
@ast
3,4-Methylenedioxymethamphetam ...... ontrolled oral administration.
@en
type
label
3,4-Methylenedioxymethamphetam ...... ontrolled oral administration.
@ast
3,4-Methylenedioxymethamphetam ...... ontrolled oral administration.
@en
prefLabel
3,4-Methylenedioxymethamphetam ...... ontrolled oral administration.
@ast
3,4-Methylenedioxymethamphetam ...... ontrolled oral administration.
@en
P2093
P2860
P1476
3,4-Methylenedioxymethamphetam ...... ontrolled oral administration.
@en
P2093
Allan J Barnes
David A Gorelick
Erin A Kolbrich-Spargo
Karl B Scheidweiler
Keming Yun
Nathalie A Desrosiers
Rebecca L Hartman
Robert S Goodwin
P2860
P2888
P304
P356
10.1007/S00216-013-7468-Y
P407
P577
2013-11-15T00:00:00Z